ARTICLE | Company News
Ablynx, Boehringer Ingelheim deal
October 11, 2010 7:00 AM UTC
Ablynx will receive a €3 million ($4.1 million) milestone payment from Boehringer under a 2007 deal to use Ablynx's Nanobody technology to discover, develop and commercialize up to 10 therapeutic prot...